Adrenal Bone Cardiovascular Diabetes Endocrine-Disrupting Chemicals Endocrine-Related Cancer Metabolism Neuroendocrinology Obesity Reproduction Steroid and Steroidogenesis Thyroid
New Growth Disorders SIG Coordinator!
We are pleased to announce the new Growth Disorders SIG Coordinator will be Gary Bulter. His term as will start immediately, taking over from Justin Davis and Helen Storr. Congratulations Gary and many thanks to Justin and Helen for their hard work and dedication.
DEADLINE EXTENDED: Peer Review and Audit Officer Roles
The call for Clinical Committee Audit Officer and Peer Review Officer has been extended to 1st July 2026.
There are two new openings on the Clinical Committee. It has been decided to split the role currently held by Guftar Shaikh, who's term will come to end this August.
Click here for more information about these two new roles.
Polyendocrine Metabolic Ovarian Syndrome (PMOS) is the new name for PCOS
Polyendocrine Metabolic Ovarian Syndrome: New name to improve diagnosis and care of condition affecting 170 million women worldwide. A global effort through the International PCOS Network has changed the name of a significant women’s health condition that was misunderstood to be ‘all about ovarian cysts’.
Help shape the future of thyroid research
Have your say on the future of thyroid research. Complete the survey to help identify the top 10 thyroid research areas that matter most to patients, carers and healthcare professionals.